Education And Debate

Education and debateMaking regulation responsive to commercial interests: streamlining drug industry watchdogsCommentary: Concern over drug industry's influence on regulatory policy in EuropeCommentary: Much ado about a good thingCommentary: The freedom of informed choice

BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7373.1164 (Published 16 November 2002) Cite this as: BMJ 2002;325:1164